Drug Development in Bladder Cancer

Keeping Unmet Needs Front and Center

#ESMOCongress2024 starts in Barcelona. Reviewing abstracts of posters at the conference, I found 14 posters focusing on #BladderCancer.

A key question every #newproduct or #commercialization team in #pharma has: What is the value of new drug development and impact the drug would have on customers. The Knolens AI Engine was asked to assess what are the unmet needs by patient population - and in 2 clicks and 30 seconds, it shared a definitive summary (snippets below).

What was impressive was that it ignored irrelevant articles that will often come up on public search engines if one ran a string search.

The goal is closer integration of #HEOR, #pricinganalysis, #ClinicalStudy design, New Product development as ways of increasing efficacy in the development process. And www.knolens.com is accelerating this effort.